Putnam Investments’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.42M Buy
16,811
+4,373
+35% +$708K ﹤0.01% 569
2023
Q3
$2.47M Buy
12,438
+2,468
+25% +$622K ﹤0.01% 677
2023
Q2
$3.24M Sell
9,970
-1,291
-11% -$369K ﹤0.01% 596
2023
Q1
$2.64M Sell
11,261
-1,942
-15% -$491K ﹤0.01% 656
2022
Q4
$3.33M Sell
13,203
-565
-4% -$120K 0.01% 603
2022
Q3
$2.44M Buy
13,768
+1,752
+15% +$352K ﹤0.01% 692
2022
Q2
$2.19M Sell
12,016
-1,774
-13% -$354K ﹤0.01% 712
2022
Q1
$3.54M Sell
13,790
-1,950
-12% -$446K 0.01% 699
2021
Q4
$3.62M Buy
+15,740
New +$3.84M 0.01% 642

Other funds holding INSP

Putnam Investments's INSP Position: Q4 2023 in Review

Putnam Investments increased its Inspire Medical Systems (INSP) stake by 35% in Q4 2023, buying an estimated $708K and bringing the position to 16,811 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Putnam Investments first reported a position in INSP in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.62M in Q4 2021. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Putnam Investments held 16,811 shares of Inspire Medical Systems worth $3.42M as of Q4 2023.
  • Putnam Investments bought 4,373 Inspire Medical Systems shares in Q4 2023, an estimated $708K.
  • Inspire Medical Systems made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #569 holding.
  • Putnam Investments first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 9 quarters since.
  • Putnam Investments's Inspire Medical Systems position peaked at $3.62M in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.